Skip to content
healthcare.dev

Mozobil

NDC 0024-5862, PLERIXAFOR, injection, solution, from Sanofi-Aventis U.S. LLC.

Product NDC
0024-5862
Status
Listed
Labeler
Sanofi-Aventis U.S. LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022311
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5862 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PLERIXAFOR24 mg/1.2mL

Pharmacologic classes

Hematopoietic Stem Cell Mobilizer [EPC]; Increased Hematopoietic Stem Cell Mobilization [PE]

Package NDCNDC-11Package
0024-5862-01000245862011 VIAL, SINGLE-USE in 1 CARTON (0024-5862-01) / 1.2 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0ed08d2b-5051-46b2-aa37-1d6275bf9003
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0024-5862

Use it

Look up 0024-5862 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5862 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0024-5862. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.